- Corporate Officers - L
- Loven Jakob
Insider Trading History of Loven Jakob
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Loven Jakob since 2018.
This trader's CIK number is 1753644.
At the time of last reporting, Loven Jakob was the Director of Kronos Bio, Inc.. (stock ticker symbol KRON).
Also see all insider trading activities at Kronos Bio, Inc..
Note that in the past
Loven Jakob also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Kronos Bio, Inc. (KRON) by Loven Jakob
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | KRON | 0 | $0 | 243,807 | $5,878,259 | 0 | $0 |
Yearly summary of insider trading at Arvinas, Inc. (ARVN) by Loven Jakob
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | ARVN | 312,500 | $5,000,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Loven Jakob:
1. Kronos Bio, Inc. (KRON)
2. Arvinas, Inc. (ARVN)
Table 1. Insider trading of Kronos Bio, Inc. (KRON) by Loven Jakob
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-04-16 | KRON | Sale | 33,162 | 21.20 | 703,034 |
| 2021-04-19 | KRON | Sale | 14,004 | 20.82 | 291,493 |
| 2021-04-20 | KRON | Sale | 21,551 | 20.36 | 438,886 |
| 2021-04-13 | KRON | Sale | 17,020 | 24.31 | 413,756 |
| 2021-04-14 | KRON | Sale | 32,636 | 22.74 | 742,142 |
| 2021-04-15 | KRON | Sale | 24,818 | 21.78 | 540,536 |
| 2021-04-08 | KRON | Sale | 63,128 | 27.50 | 1,736,020 |
| 2021-04-09 | KRON | Sale | 21,660 | 27.20 | 589,152 |
| 2021-04-12 | KRON | Sale | 15,828 | 26.74 | 423,240 |
Table 2. Insider trading of Arvinas, Inc. (ARVN) by Loven Jakob
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-10-01 | ARVN | Buy | 312,500 | 16.00 | 5,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Loven Jakob
(Director of Kronos Bio, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.